← All organizations
Highest phase reached
Phase 2
First clinical trial
Aug 17, 2017Last known activity
Aug 22, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT05290597Overall official - principal investigatorPhase 1Aug 22, 2022
- NCT05028478Overall official - principal investigatorPhase 1/Phase 2Oct 22, 2021
- NCT03505528CollaboratorPhase 1Aug 17, 2017
Details
- Last known activity
- Aug 22, 2022